BIRC5 and invasive breast carcinoma: In our study, in the case of invasive breast cancer, expression was observed in 50% of cases (8/16), which is not consistent with the results of Al-Joudi et al. [34] who observed survivin expression in 68.1% (260/382) of invasive cancers.